OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
January 03, 2022
Dosage form and patient needs drive excipient choice.
Poor solubility remains a big issue for drug development and, as such, is driving innovation in approaches and use of novel technologies to help overcome the associated challenges.
December 03, 2021
Polymeric amorphous solid dispersions are the most commonly used technology, but amorphous APIs remain inherently unstable.
November 12, 2021
Gernot Warnke, Head of R&D, JRS Pharma, spoke about excipients and how these relate to feeding in batch and continuous manufacturing.
October 15, 2021
Advanced powder testing is a useful tool to differentiate materials and optimize the supply chain.
October 02, 2021
A new program will test the safety and suitability of new inactive ingredients to encourage the accelerated adoption of FDA-accepted excipients in drug development.
September 03, 2021
Consistency, robustness, and understanding of the API and controlled-release excipients are essential for successful drug dosing.
The potential for okra gum as a polymer candidate for new oral drug formulations was evaluated.
July 03, 2021
Advances in technology are accelerating the development and manufacture of subunit vaccines, an established class of vaccines.
Bi-layer tablets are an under-utilized option that can be employed to help reduce treatment burden, but their formulation is more complex than for conventional monolayer products.